Literature DB >> 11122875

Neurosurgical advances in the treatment of brain tumors.

J J Olson1.   

Abstract

Surgery remains an important part of the treatment of primary malignant brain tumors. When surgery is utilized, care must be taken to maximize the safety of the procedures. This article emphasizes advances in lesion localization within the brain and technology used to identify the function of normal tissue around the tumor. Many of the new treatment paradigms involve a surgical procedure. For example, surgery is necessary for biodegradable treatment delivery systems, and for some focal radiation therapy. Neurosurgeons are familiar with implantable catheter systems for other types of disease such as hydrocephalus; however, there is now an opportunity to take advantage of such technology to assist in the delivery of treatment agents locally within a tumor. Although no specific surgical advance has offered cure of malignant tumors, surgery remains necessary for utilization of the treatment advances now becoming available.

Entities:  

Mesh:

Year:  2000        PMID: 11122875     DOI: 10.1007/s11912-000-0063-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  27 in total

Review 1.  New treatment strategies for malignant gliomas.

Authors:  N G Avgeropoulos; T T Batchelor
Journal:  Oncologist       Date:  1999

Review 2.  Intraoperative cortical mapping as a guide to the surgical resection of gliomas.

Authors:  P G Matz; C Cobbs; M S Berger
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

Review 3.  The role of radiosurgery for glial neoplasms.

Authors:  E Alexander; J S Loeffler
Journal:  Neurosurg Clin N Am       Date:  1999-04       Impact factor: 2.509

4.  Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study.

Authors:  S Valtonen; U Timonen; P Toivanen; H Kalimo; L Kivipelto; O Heiskanen; G Unsgaard; T Kuurne
Journal:  Neurosurgery       Date:  1997-07       Impact factor: 4.654

5.  Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit.

Authors:  P M Black; E Alexander; C Martin; T Moriarty; A Nabavi; T Z Wong; R B Schwartz; F Jolesz
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

6.  Direct injection of 90Y MoAbs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma: a model to estimate absorbed radiation dose.

Authors:  K Hopkins; C Chandler; J Eatough; T Moss; J T Kemshead
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

7.  Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma.

Authors:  N J Laperriere; P M Leung; S McKenzie; M Milosevic; S Wong; J Glen; M Pintilie; M Bernstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-15       Impact factor: 7.038

8.  Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.

Authors:  D D Bigner; M T Brown; A H Friedman; R E Coleman; G Akabani; H S Friedman; W L Thorstad; R E McLendon; S H Bigner; X G Zhao; C N Pegram; C J Wikstrand; J E Herndon; N A Vick; N Paleologos; I Cokgor; J M Provenzale; M R Zalutsky
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

Review 9.  Glioma invasion in the central nervous system.

Authors:  A Giese; M Westphal
Journal:  Neurosurgery       Date:  1996-08       Impact factor: 4.654

10.  Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of malignant brain-tumor resection-cavity margins.

Authors:  J F Dempsey; J A Williams; J B Stubbs; T J Patrick; J F Williamson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-09-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.